Speaker Profile
EngD, Director of Bioethics, Santa Clara U.
Biography
Guadalupe Hayes-Mota brings together artificial intelligence, biotechnology, and bioethics to address how medical innovation can better serve patients. His experience spans global biopharmaceutical operations, entrepreneurship, public policy, and education, including efforts to deliver medicines across 113 countries. His work examines how AI can advance drug discovery and precision medicine while addressing patient safety, bias, equitable access, and accountability. Through teaching, writing, and advising, he helps healthcare and biotechnology leaders translate ethical principles into practical decisions about developing and deploying emerging technologies. He focuses on ensuring that scientific breakthroughs earn public trust and reach the people who need them.
Talk
CARES: Turning AI Breakthroughs Into Trusted Medicines
Build breakthrough medicines. Earn patient trust. Guadalupe Hayes-Mota shows how his CARES framework brings clinical accuracy, equitable access, human oversight, data privacy, and social accountability into AI drug development. Leave with a practical approach to confronting bias, strengthening critical decisions, and putting patients at the center of innovation.
AI for Emerging Therapeutics Showcase:
Santa Clara University
Santa Clara University’s Markkula Center for Applied Ethics helps leaders turn ethical principles into practical decisions. Its Bioethics Program advances responsible innovation across health care, biotechnology, and AI, connecting patient safety, health equity, and accountability with the choices shaping tomorrow’s medicines.
Session Abstract – PMWC 2027 Silicon Valley
The PMWC 2027 AI for Emerging Therapeutics Showcase will provide a 15-30 minute time slot for selected companies to explore the transformative role of artificial intelligence in accelerating the discovery, development, and optimization of novel therapeutic modalities. From predictive algorithms for drug efficacy to real-time analysis in clinical trials, AI is revolutionizing the way we approach emerging therapies, including RNA-based treatments, gene editing, and personalized medicine. Industry leaders and experts will discuss AI-driven advancements, collaborative frameworks, and the challenges of integrating cutting-edge technologies into therapeutic innovation. Join us for an in-depth look at how AI is shaping the future of breakthrough therapeutics.
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
